Key terms
About INGN
Inogen, Inc. is a medical technology company, which engages in the development, manufacture, and marketing of portable oxygen concentrators used to deliver supplemental long-term oxygen therapy to patients suffering from chronic respiratory conditions. Its products include Inogen One G4 system, Inogen One G3 system, Inogen One G5 system, Inogen TAV, and Inogen at Home. The company was founded by Alison Perry, Alison K. Bauerlein, Brenton Taylor, and Byron Myers on November 27, 2001 and is headquartered in Goleta, CA.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest INGN news
Yesterday
4:35pm ET
Inogen Announces Executive VP and CMO Departure Plans
Apr 09
12:10pm ET
Analysts’ Opinions Are Mixed on These Healthcare Stocks: Inogen (INGN) and Galectin Therapeutics (GALT)
Feb 28
9:37am ET
Inogen trading resumes
Feb 28
9:32am ET
Inogen trading halted, volatility trading pause
Feb 28
5:15am ET
Needham Remains a Hold on Inogen (INGN)
Feb 27
4:09pm ET
Inogen sees Q1 revenue $73M-$74M, one estimate $80.6M
Feb 27
4:09pm ET
Inogen reports Q4 EPS ($1.14), consensus (62c)
Feb 15
7:19am ET
William Blair upgrades Inogen to Outperform on Respironics exit
Feb 15
5:36am ET
Inogen upgraded to Outperform from Market Perform at William Blair
Jan 25
4:29am ET
Inogen Announces Executive Transition and New Appointment
Jan 25
4:29am ET
Inogen Announces New Executive VP and CFO Appointment
Jan 24
4:01pm ET
Inogen names Michael Bourque CFO
No recent news articles are available for INGN
No recent press releases are available for INGN
INGN Financials
Key terms
Ad Feedback
INGN Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
INGN Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
